Medarex to Get Milestone From Amgen
13th Nov 2006, 20:17 GMT
Biopharmaceteucal Medarex said it expects licensing partner Amgen to pay the company an unspecified milestone payment after an antibody advanced into clinical trials.
Medarex to Get Milestone From Amgen related news:
- Medarex to Receive Milestone Payment from Amgen — Bio-Technology News from StratCenter.com
- Medarex to Get Milestone from Amgen and Illumina to Buy Solexa For About $600M — Financial News USA (OTC: FNWU)
- Amgen Releases Long-Term Enbrel Data — Bio-Technology News from StratCenter.com
- Amgen arthritis drug shows sustained safety and efficacy — Pharmaceutical Business Review Latest News
- National Kidney Foundation Launches New Phase of Kidney Early Evaluation Program, Names Amgen KEEP Principal Sponsor — Nephrology/ Dialysis News from StratCenter.com
- Bluetooth hits milestone: one billion devices — Mobile Magazine
- Spectrum Pharmaceuticals gets $5M milestone payment — Latest news from Los Angeles Business from bizjournals
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline — bizjournals.com Health Care:Pharmaceuticals headlines
- Meteor reaches 750,000 customer milestone — BreakingNews.ie - Business
- BYU's Rohatinsky Achieves Milestone — BYU NewsNet
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris